Causes and Metabolic Consequences of Gynecomastia in Adult Patients
Open Access
- 3 October 2019
- journal article
- research article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2019, 1-7
Abstract
Background. Gynecomastia (GM) is a benign enlargement of male breast due to glandular tissue proliferation. GM is a symptom of systemic or local hormonal disturbances, which could be associated with functional changes or pathological conditions. However, the long-lasting steroid imbalance in men with GM might exert negative influence on their metabolic health. Methods. A total of 110 adult men with symptomatic GM were included in the present retrospective cross-sectional study. Anthropometric, metabolic, and hormonal data of the patients were collected. Results. In almost 64% of GM patients, the underlying pathological condition was identified. Moreover, the development of GM was among the primary symptoms leading to the proper diagnosis in more than 40% of hypogonadal patients. The prevalence of metabolic syndrome (MS) was 53%; the highest prevalence of MS was found in patients with medication-induced GM and in the hypogonadal patients, whereas the lowest prevalence was observed in men with idiopathic postpubertal GM despite the similar degree of obesity. The lower testosterone levels were associated with more unfavorable lipid profile in the GM patients. Conclusion. The development of GM in adults might be an important symptom of an underlying gonadal disease. Moreover, it could be associated with an increased risk of metabolic disturbances. Our results support the need of detailed laboratory and hormonal investigations in patients with GM including targeted screening for metabolic disturbances. Further longitudinal studies are needed to evaluate the long-term consequences of sex hormones imbalance on cardiovascular morbidity and mortality in adults with GM.Keywords
This publication has 35 references indexed in Scilit:
- Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)BMC Endocrine Disorders, 2011
- Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- Estradiol and Metabolic Syndrome in Older Italian Men: The InCHIANTI StudyJournal of Andrology, 2010
- Gynecomastia: Pathophysiology, Evaluation, and ManagementMayo Clinic Proceedings, 2009
- Harmonizing the Metabolic SyndromeCirculation, 2009
- GynecomastiaNew England Journal of Medicine, 2007
- Guidelines of the Pituitary Society for the diagnosis and management of prolactinomasClinical Endocrinology, 2006
- The Metabolic Syndrome Is Frequent in Klinefelter’s Syndrome and Is Associated With Abdominal Obesity and HypogonadismDiabetes Care, 2006
- Anabolic steroid users’ attitudes towards physiciansAddiction, 2004
- Pubertal GynecomastiaJournal of Pediatric Endocrinology and Metabolism, 2002